Cullinan Oncology Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Cullinan Oncology Inc
TickerCGEM
CIK #0001789972
CUSIP230031106
SectorLife Sciences
IndustryBiological Products, (No Disgnostic Substances)
Phone6174104650
AddressOne Main Street Suite 520
Cambridge, MA 02142
Source [EDGAR]
Market Cap, 13F ($)
CIK Filing 2011 - 2023
[0001789972] 10-K
[0001789972] 10-Q
[0001789972] 3
[0001789972] 4
[0001789972] 5
[0001789972] 8-K
[0001789972] SC 13D
[0001789972] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Cullinan Oncology Inc [2023-02-03] 5.5
CHI Advisors LLC Cullinan Oncology Inc [2022-02-11] 5.67
Jovan-Embiricos Morana Cullinan Oncology Inc [2022-02-10] 4.8
Vanguard Group Inc Cullinan Oncology Inc [2022-02-09] 5.42
Biotechnology Value Fund L P Cullinan Oncology Inc [2021-11-08] 3.2
UBS Oncology Impact Fund LP Cullinan Management Inc [2021-01-19] 18.3
Foresite Capital Fund V LP Cullinan Management Inc [2021-01-15] 6.6
Form 3/4/5 Filer 2011 - 2023
Cullinan Oncology, Inc.
Trigilio Jeffrey
Michaelson Jennifer
Webster Stephen W
Rosenberg Anthony
Martin Anne-Marie
Ebeling Thomas
Ahmed Nadim
Jones Jeffrey Alan
Sumer Jacquelyn L
Baeuerle Patrick
Savill Corrine
Gadicke Ansbert
Lampert Mark N
Biotechnology Value Trading Fund OS LP
BVF GP Holdings LLC
BVF II GP LLC
Biotechnology Value Fund II LP
BVF Partners OS Ltd.
BVF Inc/IL
BVF Partners L P/IL
BVF I GP LLC
Biotechnology Value Fund L P
Ryan David P.
F2 Vision SCS
Jovan-Embiricos Morana
F2 Bioscience I 2017 Ltd
Keane Raymond T
Zawel Leigh
BioImpact Capital LLC
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
F2 - TPO Investments LLC
Globeways Holdings Ltd
F2 MC LLC
F2 Bio TD, LLC
F2 GC LLC
F2 MG Ltd
Hughes Owen
Wigginton Jon Marc
Shares Owned of Total
Firm Period DFND Voting Shares
Bioimpact Capital LLC [2023-03-31] SOLE 7,648,268.0 7,648,268.0
CHI Advisors LLC [2023-03-31] DFND 3,349,460.0 3,349,460.0
BVF Inc/IL [2023-03-31] DFND 0.0 3,196,701.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,524,683.0
BlackRock Inc. [2023-03-31] SOLE 2,186,618.0 2,255,597.0
American International Group Inc [2023-03-31] SOLE 1,236,349.0 1,236,349.0
Nextech Invest Ltd [2023-03-31] SOLE 1,221,145.0 1,221,145.0
Boxer Capital, LLC [2023-03-31] OTR 1,074,082.0 1,074,082.0
Franklin Resources Inc [2023-03-31] DFND 782,938.0 789,138.0
Citadel Advisors LLC [2023-03-31] DFND 627,368.0 627,368.0
Rubric Capital Management LP [2023-03-31] SOLE 626,929.0 626,929.0
OrbiMed Advisors LLC [2023-03-31] SOLE 605,387.0 605,387.0
Kennedy Capital Management LLC [2023-03-31] SOLE 554,821.0 584,942.0
State Street Corp [2023-03-31] DFND 527,414.0 562,214.0
Geode Capital Management LLC [2023-03-31] DFND 537,823.0 537,823.0
Tang Capital Management LLC [2023-03-31] OTR 0.0 500,000.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 328,885.0 331,722.0
American Century Companies Inc [2023-03-31] DFND 322,928.0 322,928.0
SilverArc Capital Management LLC [2023-03-31] SOLE 265,032.0 265,032.0
Artal Group S.A. [2023-03-31] DFND 250,000.0 250,000.0
Northern Trust Corp [2023-03-31] DFND 6,648.0 248,510.0
EcoR1 Capital LLC [2023-03-31] SOLE 246,410.0 246,410.0
Millennium Management LLC [2023-03-31] SOLE 244,553.0 244,553.0
Renaissance Technologies LLC [2023-03-31] SOLE 176,191.0 239,200.0
Assenagon Asset Management S.A. [2023-03-31] SOLE 221,340.0 221,340.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 187,533.0 187,533.0
Goldman Sachs Group Inc [2023-03-31] DFND 179,800.0 179,820.0
Parkman Healthcare Partners LLC [2023-03-31] SOLE 169,886.0 169,886.0
Morgan Stanley [2023-03-31] DFND 132,923.0 165,948.0
Hudson Bay Capital Management LP [2023-03-31] SOLE 150,000.0 150,000.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com